DK
Donggon Kim
CTO(Chief Technology Officer)
IMT inc
I'm working on
9 minutes ago
Advanced electrospinning equipment and polymer solution development services for fabricating biomedical implants and scaffolds, specifically: cardiovascular and urethral stents, small-diameter vascular grafts/AV access grafts, advanced wound care and tissue regeneration matrices.
I'm looking for
a month ago
Establishing global industry partnerships for the co-development of advanced biomedical devices and materials, while securing strategic investment and collaborative funding.
About
Ph.D. in Polymer Science & Engineering with 15+ years directing medical device R&D across industry leaders (IMT, DOF, Taewoong, NextBiomedical, Genoss). Holds 6 patents and 28 publications in drug delivery systems and medical devices. Key Expertise: Implants: Cardiovascular, non-vascular, and urethral stents; flow diverters; AV grafts; endoscopic delivery systems. Materials & Coatings: Electrospun nanofiber scaffolds, drug-eluting matrices, and functional bio-coatings. Quality Systems: ISO 13485 and KGMP facility setup and compliance. Industry Solutions Translating early-stage biomaterial R&D into GMP-compliant commercial products. Optimizing stent patency via anti-thrombotic and controlled-release coatings. Tailoring electrospun solutions for vascular grafts and wound care.
DK
Donggon Kim
CTO(Chief Technology Officer)
IMT inc
Work experience
CTO(Chief Technology Officer)
DOF Inc.
R&D Director
2023 - 2024
Spident
Team Leader
2021 - 2023
Top industry applications
Cardiovascular healthDermatological treatmentsRegenerative medicine
Expertise
Drug DeliveryMedicinal ChemistryNanomaterials
Last updated Sep 2026
Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.